Print  |  Close

Hillary A. Hahm MD, PhD

Hillary A. Hahm MD, PhD

Northwest Georgia Oncology Centers

Education and Training

Specialty and Certification

Medical Oncology / Board Certified

Clinical Trial Cancer Types

Breast Cancer, Cancer-Related Syndrome, Leukemia, Lung Cancer, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Ovarian Cancer, Solid Tumor

Affiliations

WellStar Kennestone Hospital

Active Clinical Trial Sites in Georgia

Cartersville Medical Center

960 Joe Frank Harris Parkway
Cartersville, GA 30120
770-382-1530 (p)
www.cartersvillemedical.com

driving directions

Clinical Trials


Northwest Georgia Oncology Centers - Marietta

340 Kennestone Hospital Boulevard
Suite 200
Marietta, GA 30060
770-281-5100 (p)
678-581-7109 (f)
www.ngoc.com

driving directions

Clinical Trials
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Cancer Type: Breast Cancer

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Of Fulvestrant (Faslodex®) With Or Without PD-0332991 (Palbociclib) +/- Goserelin In Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy
Cancer Type: Breast Cancer

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. (OlympiAD)
Cancer Type: Breast Cancer

Connect® Myeloid Disease Registry
Cancer Type: Cancer-Related Syndrome

Connect® Myeloid Disease Registry
Cancer Type: Leukemia

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Cancer Type: Lung Cancer

Connect® Myeloid Disease Registry
Cancer Type: Myelodysplastic Syndromes (MDS)

A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-agent Maintenance Versus Rituximab Maintenance in Subjects With Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma
Cancer Type: Non-Hodgkin Lymphoma

A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0010718C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Cancer Type: Ovarian Cancer

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Cancer Type: Solid Tumor


WellStar Kennestone Hospital

677 Church Street
Marietta, GA 30060
770-793-5000 (p)
www.wellstar.org

driving directions

Clinical Trials

Active Clinical Trial Site Locations:

**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.